What's the Cheapest Legal Way to Get Your GLP-1? (Updated July 2026)
The cheapest legal way to get your GLP-1 depends on how you pay. If your commercial plan covers it, a stable copay — as low as $25/month with a manufacturer savings card — usually wins. On Medicare, the GLP-1 Bridge is $50/month. Paying cash, self-pay starts at $149/month, and some uninsured patients qualify for $0 assistance. Pick your situation below.
Find your cheapest path
Semaglutide (Wegovy) · Commercial insurance — covers GLP-1s
If your copay is stable, you don't need anything else — including us.
- Wegovy savings card (commercial insurance) $25/mo
as of Jul 28, 2026
The catch: Eligible commercial insurance only — Medicare, Medicaid and other government plans are excluded. Savings are capped at $100/month.
View primary source ↗
Members get this refreshed monthly with same-week price alerts → /cost-tracker
Every situation, side by side (July 2026)
The cheapest legal way to get a GLP-1 depends entirely on how you pay. If your commercial plan already covers it, a stable copay usually beats every workaround. If you're on Medicare, the GLP-1 Bridge is $50/month while it runs. If you're paying cash, manufacturer self-pay pricing and, for some uninsured patients, a $0 patient-assistance program are the real floors. Every price below carries an as-of date and a primary source.
| Situation | Medication | Cheapest verified option | Monthly price (as of) | The catch | Source |
|---|---|---|---|---|---|
| Commercial insurance — covers GLP-1s | Semaglutide (Wegovy) | Wegovy savings card (commercial insurance) | $25/mo (as of Jul 28, 2026) | Eligible commercial insurance only — Medicare, Medicaid and other government plans are excluded. Savings are capped at $100/month. | Source ↗ |
| Commercial insurance — covers GLP-1s | Tirzepatide (Zepbound) | Zepbound savings card (commercial insurance) | $25/mo (as of Jul 28, 2026) | Commercial insurance only; applies to the single-dose pen. The savings card expires 12/31/2026 and caps annual savings at $1,300. | Source ↗ |
| Commercial insurance — covers GLP-1s | Foundayo (oral orforglipron) | Your plan copay + Lilly savings card | Your plan copay — varies | We could not verify a single published commercially-insured price for Foundayo — it depends on your plan and the live savings offer. | Source ↗ |
| Commercial insurance — excludes GLP-1s | Semaglutide (Wegovy) | Wegovy self-pay (NovoCare) | $349/mo (0.25–2.4 mg pen) (as of Jul 28, 2026) | Intro price is $199/mo for the first 2 months (0.25/0.5 mg), then $349/mo. The 7.2 mg pen is $399/mo; oral Wegovy self-pay starts at $149/mo. | Source ↗ |
| Commercial insurance — excludes GLP-1s | Tirzepatide (Zepbound) | Zepbound self-pay (LillyDirect) | $299–$449/mo (as of Jul 28, 2026) | You must refill within 45 days of delivery or the price reverts to $499–$699. Single-dose vials are $299; KwikPens are $399–$449 by dose. | Source ↗ |
| Commercial insurance — excludes GLP-1s | Foundayo (oral orforglipron) | Foundayo self-pay (LillyDirect) | $149–$349/mo (as of Jul 28, 2026) | $149/mo for 0.8 mg, rising to $349/mo for 14.5–17.2 mg. Some higher-dose offers depend on refill timing. | Source ↗ |
| Medicare | Semaglutide (Wegovy) | Medicare GLP-1 Bridge | $50/mo (as of Jul 28, 2026) | Zepbound is covered as the KwikPen only. Requires Part D; you can't already be getting a GLP-1 through Part D; excludes people diagnosed with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The $50 copay does not count toward your deductible or out-of-pocket cap. Runs July 1, 2026 – December 31, 2027. | Source ↗ |
| Medicare | Tirzepatide (Zepbound) | Medicare GLP-1 Bridge | $50/mo (as of Jul 28, 2026) | Zepbound is covered as the KwikPen only. Requires Part D; you can't already be getting a GLP-1 through Part D; excludes people diagnosed with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The $50 copay does not count toward your deductible or out-of-pocket cap. Runs July 1, 2026 – December 31, 2027. | Source ↗ |
| Medicare | Foundayo (oral orforglipron) | Medicare GLP-1 Bridge | $50/mo (as of Jul 28, 2026) | Zepbound is covered as the KwikPen only. Requires Part D; you can't already be getting a GLP-1 through Part D; excludes people diagnosed with type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The $50 copay does not count toward your deductible or out-of-pocket cap. Runs July 1, 2026 – December 31, 2027. | Source ↗ |
| Medicaid | Semaglutide (Wegovy) | State Medicaid (where covered) | $0–low copay where covered; otherwise self-pay (Jul 28, 2026) | State-by-state with prior authorization and BMI rules. As of January 2026 only ~13 state Medicaid programs cover GLP-1s for weight loss. | Source ↗ |
| Medicaid | Tirzepatide (Zepbound) | State Medicaid (where covered) | $0–low copay where covered; otherwise self-pay (Jul 28, 2026) | State-by-state with prior authorization and BMI rules. As of January 2026 only ~13 state Medicaid programs cover GLP-1s for weight loss. | Source ↗ |
| Medicaid | Foundayo (oral orforglipron) | State Medicaid (where covered) | $0–low copay where covered; otherwise self-pay (Jul 28, 2026) | State-by-state with prior authorization and BMI rules. As of January 2026 only ~13 state Medicaid programs cover GLP-1s for weight loss. | Source ↗ |
| Uninsured / paying cash | Semaglutide (Wegovy) | Novo Nordisk Patient Assistance Program | $0 (as of Jul 28, 2026) | Uninsured with income limits only — not available if you have any commercial or government drug coverage. Application and approval are required before you receive medication. | Source ↗ |
| Uninsured / paying cash | Tirzepatide (Zepbound) | Zepbound self-pay (LillyDirect) | $299–$449/mo (as of Jul 28, 2026) | You must refill within 45 days of delivery or the price reverts to $499–$699. Single-dose vials are $299; KwikPens are $399–$449 by dose. | Source ↗ |
| Uninsured / paying cash | Foundayo (oral orforglipron) | Foundayo self-pay (LillyDirect) | $149–$349/mo (as of Jul 28, 2026) | $149/mo for 0.8 mg, rising to $349/mo for 14.5–17.2 mg. Some higher-dose offers depend on refill timing. | Source ↗ |
Frequently asked questions
- What is the cheapest legal way to get a GLP-1 in 2026?
- It depends on how you pay. If your commercial plan covers GLP-1s, a stable copay (as low as $25/month with a manufacturer savings card for Wegovy or Zepbound) is usually the cheapest. On Medicare, the GLP-1 Bridge is $50/month through December 31, 2027. Uninsured patients who meet income limits may qualify for Novo Nordisk's $0 patient-assistance program; otherwise, self-pay brand pricing starts at $149/month for oral Foundayo.
- How much is Wegovy or Zepbound without insurance?
- As of July 28, 2026, Wegovy self-pay is $349/month for the standard pen ($199/month intro for the first two months) and the 7.2 mg pen is $399/month. Zepbound self-pay is $299 for single-dose vials and $399–$449 for KwikPens, but you must refill within 45 days or the price reverts to $499–$699.
- What is the Medicare GLP-1 Bridge and who qualifies?
- The Medicare GLP-1 Bridge is a temporary program that gives eligible Part D enrollees Wegovy, Zepbound (KwikPen only), or Foundayo for a flat $50/month copay for weight management. It runs July 1, 2026 through December 31, 2027. You must have Part D, not already be receiving a GLP-1 through Part D, and not have a diagnosis of type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease. The $50 copay does not count toward your deductible or out-of-pocket cap.
- Does Medicaid cover GLP-1s for weight loss?
- Only in some states. As of January 2026, roughly 13 state Medicaid programs cover GLP-1s for obesity treatment, usually with prior authorization and BMI criteria. Several states (including California, New Hampshire, Pennsylvania, and South Carolina) ended coverage on January 1, 2026. Always confirm with your state's current Medicaid formulary.
- Can I use a manufacturer savings card if I have Medicare or Medicaid?
- No. Manufacturer savings cards for Wegovy and Zepbound exclude government beneficiaries, including Medicare and Medicaid. Those programs have their own paths — the Medicare GLP-1 Bridge and state Medicaid coverage.
- Is oral Foundayo cheaper than the injectable GLP-1s?
- For cash-pay patients, yes. Foundayo (oral orforglipron) self-pay starts at $149/month for the 0.8 mg dose through LillyDirect, rising to $349/month at the highest doses — the lowest brand GLP-1 self-pay entry point we verified as of July 28, 2026.
All prices verified against their primary sources as of Jul 28, 2026. Every figure here is tracked in our monthly GLP-1 Price Index.